Looking forward to hearing Susanne Gatz and Julia Glade Bender, MD speak at 11:45 AM today 👩‍❤️‍👨🥰❤️ clinical trials plenary.

Excited to present on our patient partnered research on osteosarcoma and leiomyosarcoma next month!!

The OSI is attending #ASCO2023 this week in Chicago, IL along with global cancer experts to discover the latest innovations in cancer research and education. Learn more at conferences.asco.org.

great to see nice work from collaborators at the #ASCO2023 sarcoma poster session. Andy Livingston, MD MS

Great to see The Osteosarcoma Institute and quadwfoundation leaders in Chicago @ASCO2023 (Mary Katherine Clark was the photographer)

It’s been an honor to be an associate editor JCO Precision Oncology. Passing the pediatric torch to Theodore Laetsch

⁦So happy to see work done by Maeve Smart ⁦The Janeway Lab⁩ about Covid-19 infection in pediatric cancer patients at #ASCO2023

It is the anniversary of our patient partnered osteosarcoma project — osproject.org — creating a clinico-genomic database for the research community to drive discovery. Patients enroll online. Consider referring your patients during #childhoodcancerawareness month

‼️🆕Thrilled to share our groundbreaking work just published in Nature Medicine 🔥 There is the unmet medical need to implement novel #ClinicalTrial designs in patients with #RareTumors to: 1) Facilitate clinical research🏥 2) Speed up drug approvals💊 ➡️nature.com/articles/s4159…

Great meeting Univ. of New Mexico hosted by Cheryl Willman, M.D. discussing patient engagement in cancer genome research with this outstanding osproject.org and lmsproject.org team.

Fantastic #CTOS2023 meeting organized by this team!!!

So lucky to work at Dana-Farber. Congratulations Dr. Glimcher.

Such important work you all do! Thank you.

#AACR24 so lucky to know many of the impressive cancer researchers named AACR Fellows of the Academy this morning. Congratulations!! David Malkin and others it on X

#ASCO24 great session on #sarcoma biomarkers Riaz Gillani and David Shulman from Dana-Farber presented validation of prognostic impact of STAG2 loss in Ewing and elevated ctDNA in osteo. Congrats to investigators and discussants!!

⁦Dana-Farber⁩ (inclusive of alums) at ⁦MIB Agents Osteosarcoma Alliance⁩ Factor #osteosarcoma meeting. Great science, company and fun!

Eirian Siegal-Botti from ⁦⁦Count Me In⁩ and ⁦Broad Institute⁩ presenting ⁦PE-CGS⁩ ⁦The Osteosarcoma Project⁩ MIB Agents Osteosarcoma Alliance⁩ Factor conference. Thanks to ⁦MIB Agents Osteosarcoma Alliance⁩ and #osteosarcoma participants for your partnership in research.

Hooray to JAMA Oncology for focussing on rare cancer

New work from the The Janeway Lab reporting on a pediatric cancer patient cohort sequenced Dana-Farber with 95! different cancer diagnoses. So important to share data to learn about Rare Cancer rdcu.be/dNt1d